manilatimes3d
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) (NASDAQ:BRTX), a clinical stage regenerative ...
BioRestorative Therapies, Inc: BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting - - IND clearance expands Company's advanced clinical pipeline for ...
theloopnewspaper16d
Do you feel like no one is listening?
Do you ever feel like no one is listening to you? Where do you feel that frustration in your body? Take a moment to think ...
Repeated eight-hour desk days can lead to gluteal amnesia, a potentially debilitating condition
When you take a step forward, the glutes should activate first. But when you sit, muscles on the front of the hip and thigh ...
Business Wire19d
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for seriou ...